Pilot Study of Laurus nobilis Tea on Oxidant/Antioxidant Stress Biomarkers in Healthy North-African Volunteers

Randomized, Placebo-Controlled Pilot Study of Laurus nobilis Tea on Oxidant/Antioxidant Stress Biomarkers in Healthy North-African Volunteers

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202205671550114

Enrollment

Registered

2022-05-11

Start date

2022-05-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Cardiology

Interventions

Laurus nobilis tea

Origanum syriacum L

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: no smoking no vegetarian diet no pregnancy no consumption of medication or nutritional supplements no chronic pathologies (eg; cardiovascular diseases, diabetes-mellitus, arterial-hypertension, asthma, psychiatric disorders, gastrointestinal problems) no food allergy.

Exclusion criteria

Exclusion criteria: Absence during the second visit (ie; Day11 of the study) Non-consumption of the Laurus nobilis tea at least one time

Design outcomes

Primary

Measure	Time frame
low-density lipoprotein (LDL) receptor (LDL-R)	—

Secondary

Measure	Time frame
CP: Carbonylated proteins HDL-C: High-density lipoprotein cholesterol LDL-C: Low-density lipoprotein cholesterol SOD: Superoxide dismutase TC: Total cholesterol TG: Triglycerides UA: Uric acid	—

Countries

Tunisia

Contacts

Public ContactChahra CHBILI

Metabolic Biophysics Applied Pharmacology Laboratory

chahrachbili@yahoo.fr+21693645001

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026